Balyasny Asset Management
BNGO icon

Balyasny Asset Management’s Bionano Genomics BNGO Stock Holding History

Balyasny Asset Management’s Portfolio BNGO Stock Details BNGO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-888
Closed -$325K – 2271
2023
Q2 		$325K Sell
888
-73
-8% -$33K ﹤0.01% 1967
2023
Q1 		$640K Buy
961
+683
+246% +$607K ﹤0.01% 1887
2022
Q4 		$244K Buy
278
+156
+128% +$196K ﹤0.01% 2065
2022
Q3 		$133K Buy
+122
New +$161K ﹤0.01% 2378
2022
Q1 		– Sell
-29
Closed -$51K – 2485
2021
Q4 		$51K Buy
+29
New +$77.6K ﹤0.01% 2068

Other funds holding BNGO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
GC
GMT Capital Atlanta, Georgia $2.19B AUM 72.3% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Mitsubishi UFJ Asset Management
Mitsubishi UFJ Asset Management Tokyo, Japan $149B AUM 24.71% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Mirae Asset Global Investments
Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Balyasny Asset Management's BNGO Position: Q3 2023 in Review

Balyasny Asset Management sold out of Bionano Genomics (BNGO) in Q3 2023, closing a stake of 888 shares — an estimated $325K sold.

Balyasny Asset Management first reported a position in BNGO in Q4 2021 and held it in 5 quarters. The position peaked at $640K in Q1 2023. 46 funds tracked by Wall St. Rank hold BNGO as of Q3 2023.

  • Balyasny Asset Management reported no remaining Bionano Genomics position as of Q3 2023 after selling out during the quarter.
  • Balyasny Asset Management sold 888 Bionano Genomics shares in Q3 2023, an estimated $325K.
  • Balyasny Asset Management first reported a position in Bionano Genomics in Q4 2021 and held it in 5 quarters.
  • Balyasny Asset Management's Bionano Genomics position peaked at $640K in Q1 2023.
  • 46 funds tracked by Wall St. Rank held Bionano Genomics as of Q3 2023.

Based on Balyasny Asset Management's 13F filing for Q3 2023, filed 14 Nov 2023.